EconomyRoche signs obesity drug licensing deal worth up to $1.16 billion with China's Rona Therapeutics
Swiss drugmaker Roche has agreed to license an investigational obesity drug candidate from Chinese biotech firm Rona Therapeutics in a deal worth up to $1.16 billion, Rona said on Tuesday.
R
Reuters★★☆☆☆2026-10-13 08:25Original
Roche signs obesity drug licensing deal worth up to $1.16 billion with China's Rona Therapeutics
Economy